Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 18 and up Women only

Does standardizing cervical ripening improve vaginal deliveries?

Official title: Impact of Standardization on Outcomes Following Cervical Ripening

Run by Indiana University · NCT07576881 · Data updated 2026-11-12

This study tests whether using standardized methods to ripen the cervix helps more pregnant people have vaginal deliveries.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment1158 (estimated)
SponsorIndiana University
Academic / other
Locations1 site (Indianapolis, Indiana)
StatusRecruiting
StartedJuly 29, 2026
Main results expectedDecember 2027
Study endsApril 2028
Registry record updatedOctober 27, 2026
Trial IDNCT07576881 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older scheduled for medically indicated or elective induction at ≥37 weeks gestation, able to consent and read English, Spanish, or Haitian Creole.

Probably not a fit

Patients with cervical or fetal conditions that necessitate alternative management or those who do not undergo induction may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This Phase 2/3 trial compares three approaches to cervical ripening in labor induction: double balloon catheter alone, double balloon catheter with misoprostol, and usual care. The primary outcome is the rate of spontaneous vaginal delivery, with secondary outcomes including time to delivery, total hospital stay, operative delivery, tachysystole, fetal status interventions, and maternal and neonatal morbidity and length of stay. The study enrolls pregnant patients at ≥37 weeks undergoing indicated or elective induction at Eskenazi Hospital, with consent and language access in English, Spanish, or Haitian Creole. Results will inform whether standardizing ripening methods improves labor outcomes and whether different methods have distinct effects on maternal and neonatal safety.

Why it matters

Potential benefit: If successful, standardizing cervical ripening could increase vaginal delivery rates and improve overall labor outcomes for patients undergoing induction.

How similar studies have gone: Previous research in labor induction has explored standardized approaches, with mixed results; this trial extends to a combined, multi-arm comparison in a real-world setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who are scheduled for medically indicated or elective induction of labor with gestational age ≥37 weeks at Eskenazi hospital
* Willing and able to provide informed consent
* Age ≥18 years old
* Able to read, speak and understand English, Spanish or Haitian Creole

Exclusion Criteria:

* Premature rupture of membranes
* Known chorioamnionitis
* Fetal malpresentation
* Placenta previa
* Category 3 fetal heart rate tracing -- only at the time of screening and enrollment. If a Category III tracing develops later in labor, this will prompt standard obstetric management, not removal from the study.
* Prior uterine scar (cesarean delivery or other contraindication to use of prostaglandins)
* Major fetal anomalies known at the time of enrollment that are expected to meaningfully impact labor management
* Multiple gestation
* Allergy to misoprostol or other contraindication to induction of labor or use of misoprostol or cook cervical ripening balloon
* Patient does not require cervical ripening (SBS ≥ 6 or dilation ≥ 4cm)
* Significant acute or chronic medical, neurologic, or illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study

Where it's running

  • Sidney & Lois Eskenazi Hospital
    Indianapolis, Indiana, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.